Is LLY a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

6,784 people get LLY articles and Market Currents by email alert.

Get email alerts on LLY »

HEADLINES:

6 Ways You Can Profit From Molecular Diagnostics
Cory Renauer • Wed, May 22 • 8 Comments
Pricing A Highly Probable Takeover Of MannKind
George Rho • Wed, May 22 • 52 Comments
From Research Labs to Doctors' Offices, Health Care Providers at Lilly Play Important Role in Bringing New and Innovative Medicines to Patients

PR Newswire (Mon, 8:00AM)
What Will $2 Million Get You In Retirement?
Doug Carey • Thu, May 16 • 147 Comments
Lilly Oncology to Release New Pipeline Data at ASCO 2013

PR Newswire (May 14, 2013)
Lilly Provides Update on CEO Dr. John Lechleiter

PR Newswire (May 14, 2013)
10 Hot Healthcare Dogs Probe 6% To 38.2% Gains In April
Fredrik Arnold • Mon, May 13 • 2 Comments
Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?
C.R. Jackson • Sun, May 12 • 2 Comments
Letting Statistics Help You See What You Want To See
George Acs • Sun, May 12 • 7 Comments
Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma

PR Newswire (May 10, 2013)
Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Arrived
The Progressive • Thu, May 9 • 60 Comments
3 Bio Companies Facing The Patent Cliff
Emerging Equities • Tue, May 7 • 1 Comment
Retrospective analysis of linagliptin data in sub-populations with type 2 diabetes presented at AACE 22nd Annual Scientific & Clinical Congress

PR Newswire (May 6, 2013)
After AbbVie's Humira: What Next?
Peter Geschek • Mon, May 6 • 1 Comment
Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery

PR Newswire (May 6, 2013)
Lilly Declares Second-Quarter 2013 Dividend

PR Newswire (May 6, 2013)
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes

PR Newswire (May 2, 2013)
Cramer's Mad Money - Pharmas Live Or Die By The Pipeline (5/1/13)
SA Editor Miriam Metzinger • Thu, May 2
The Importance of Emergency Preparedness: Lilly Diabetes and the American College of Endocrinology (ACE) Help Prep People with Diabetes for Emergencies - Big or Small

PR Newswire (May 1, 2013)
Want To Retire Before 60? Here Is What You Need To Know
Doug Carey • Wed, May 1 • 84 Comments

To learn more about Seeking Alpha Pro, click here.

Eli Lilly's Promising Stage III Pipeline Could Jumpstart Its Dividend
Valuentum • Fri, Apr 26
Whisper Number Impact: Earnings Preview For Eli Lilly
WhisperNumber • Tue, Apr 23
Eli Lilly's Big Bet On Diabetes
Peter Geschek • Tue, Apr 23 • 1 Comment
Clean Superiority Sweep For Dulaglutide Could Reshape Diabetes Market
EP Vantage • Wed, Apr 17 • 1 Comment
Reasons To Consider Eli Lilly Over Other Pharmaceutical Giants
Robinson Roacho • Fri, Mar 22 • 4 Comments
Eli Lilly: A Bull Run Corroborated By Its Fundamentals
StockRiters • Wed, Mar 6 • 3 Comments
2013, A Year Of Turmoil For Eli Lilly
Bio Matt • Sat, Feb 16 • 4 Comments
Eli Lilly May Have The Best Chance At Keeping The Momentum Going
Stephen Simpson • Wed, Jan 30 • 1 Comment
Pfizer And Eli Lilly Sit At New Highs; Which Is The Better Buy?
Teresa Dawn • Wed, Jan 30 • 6 Comments
Eli Lilly: Buy, Sell Or Hold
Pharma Reports • Wed, Jan 9 • 5 Comments
Eli Lilly's Strong Outlook Is Comforting Amidst $6 Billion In Patent Expirations
The Value Investor • Sun, Jan 6 • 4 Comments
Eli Lilly's Brave Alzheimer's Talk
Derek Lowe • Wed, Dec 12, 2012 • 3 Comments
Why Eli Lilly Is Worth Every Penny
Valuentum • Tue, Dec 11, 2012 • 2 Comments
Pfizer's Xeljanz Gets Approval, While Lilly's Baricitinib Looks Strong
Kevin CC • Wed, Nov 21, 2012 • 8 Comments
Lilly: The Worst Play In Big Pharma?
Cris Frangold • Thu, Nov 15, 2012 • 6 Comments
Eli Lilly: Cymbalta Patent Cliff
Pharma Reports • Thu, Nov 1, 2012
Is Eli Lilly Still A Solid Dividend Investment For The Long Run?
Doug Carey • Wed, Oct 31, 2012 • 1 Comment
Could It Be An 'Alzheimer's Bonanza'?
Stock Traders Daily • Tue, Oct 23, 2012 • 1 Comment
Should Investors Be Concerned About Eli Lilly?
Mel Daris • Tue, Oct 23, 2012
Eli Lilly: Positive Development Of Gastric Cancer Drug Makes Us Bullish On The Stock
Qineqt • Tue, Oct 16, 2012

6 Ways You Can Profit From Molecular Diagnostics
Cory Renauer • Wed, May 22 • 8 Comments
Pricing A Highly Probable Takeover Of MannKind
George Rho • Wed, May 22 • 52 Comments
What Will $2 Million Get You In Retirement?
Doug Carey • Thu, May 16 • 147 Comments
10 Hot Healthcare Dogs Probe 6% To 38.2% Gains In April
Fredrik Arnold • Mon, May 13 • 2 Comments
Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?
C.R. Jackson • Sun, May 12 • 2 Comments
Letting Statistics Help You See What You Want To See
George Acs • Sun, May 12 • 7 Comments
Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Arrived
The Progressive • Thu, May 9 • 60 Comments
3 Bio Companies Facing The Patent Cliff
Emerging Equities • Tue, May 7 • 1 Comment
After AbbVie's Humira: What Next?
Peter Geschek • Mon, May 6 • 1 Comment
Cramer's Mad Money - Pharmas Live Or Die By The Pipeline (5/1/13)
SA Editor Miriam Metzinger • Thu, May 2
Want To Retire Before 60? Here Is What You Need To Know
Doug Carey • Wed, May 1 • 84 Comments
No News Becoming Bad News For Lexicon Pharmaceuticals
Stephen Simpson • Tue, Apr 30 • 10 Comments
Transition Therapeutics Still Undervalued: Good Trial Outcome Shifts Focus To Lilly Decision
PropThink • Tue, Apr 30 • 2 Comments
The 3 Drivers Behind The Big Pharma Rally
BubbleBustInvesting • Thu, Apr 25 • 3 Comments
Cramer's Mad Money - National Lemming Day (4/24/13)
SA Editor Miriam Metzinger • Thu, Apr 25
Will The Big Pharmaceuticals Fall Off A Patent Cliff?
Fund Gurus • Wed, Apr 24 • 2 Comments
Why Did Vanda Pharmaceuticals Hit A 52-Week High?
C.R. Jackson • Fri, Apr 19 • 2 Comments
PetMed Express: This Stock Is No Dog
Henry Kawabe • Thu, Apr 18 • 1 Comment
Amarantus' LymPro Could Be A Game-Changer For Alzheimer's Diagnosis
Jason Napodano • Wed, Apr 17 • 16 Comments
China Biotech In Review: Lilly Invests $100 Million In China Animal Healthcare
ChinaBio Today • Sun, Apr 14

Eli Lilly's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Wed, Apr 24
Eli Lilly Management Presents at 2013 Barclays Global Healthcare Conference (Transcript)
Tue, Mar 12
Eli Lilly's Management Discusses Q4 2012 Results - Earnings Call Transcript
Tue, Jan 29
Eli Lilly & Company's CEO Hosts 2013 Financial Guidance Conference (Transcript)
Fri, Jan 4
Eli Lilly & Co. Management Discusses Q3 2012 Results - Earnings Call Transcript
Wed, Oct 24, 2012
Eli Lilly & Co. Management Discusses Q2 2012 Results - Earnings Call Transcript
Wed, Jul 25, 2012 • 1 Comment
Eli Lilly's Management Host Lilly Diabetes Pipeline Update Call (Transcript)
Tue, Jun 12, 2012
Eli Lilly & Co.'s CEO Discusses Q1 2012 Results - Earnings Call Transcript
Wed, Apr 25, 2012
Eli Lilly Management Host Ixekizumab Phase II Psoriasis Data Conference Call (Transcript)
Tue, Apr 10, 2012
Eli Lilly & Co.'s CEO Discusses Q4 2011 Results - Earnings Call Transcript
Tue, Jan 31, 2012 • 1 Comment
Eli Lilly's CEO Presents at The 30th Annual JPMorgan Chase Healthcare Conference (Transcript)
Wed, Jan 11, 2012
Eli Lilly & Co.'s CEO Discusses Q3 2011 Results - Earnings Call Transcript
Thu, Oct 20, 2011 • 1 Comment
Eli Lilly & Co. Management Discusses Q2 2011 Results - Earnings Call Transcript
Thu, Jul 21, 2011
Eli Lilly & Co. Management Discusses Q1 2011 Results - Earnings Call Transcript
Mon, Apr 18, 2011 • 1 Comment
Eli Lilly & Co.'s CEO Discusses Q4 2010 Results - Earnings Call Transcript
Thu, Jan 27, 2011
Eli Lilly & Co. CEO Discusses Q3 2010 Results - Earnings Call Transcript
Thu, Oct 21, 2010
Eli Lilly & Co. Q2 2010 Earnings Call Transcript
Thu, Jul 22, 2010
Eli Lilly and Company Q1 2010 Earnings Call Transcript
Mon, Apr 19, 2010 • 1 Comment
Eli Lilly and Co. Q4 2009 Earnings Call Transcript
Thu, Jan 28, 2010 • 1 Comment
Eli Lilly and Company Q3 2009 Earnings Call Transcript
Wed, Oct 21, 2009

From Research Labs to Doctors' Offices, Health Care Providers at Lilly Play Important Role in Bringing New and Innovative Medicines to Patients

PR Newswire (Mon, 8:00AM)
Lilly Oncology to Release New Pipeline Data at ASCO 2013

PR Newswire (May 14, 2013)
Lilly Provides Update on CEO Dr. John Lechleiter

PR Newswire (May 14, 2013)
Lilly To Take $30M Charge After Disappointing Drug Trial

at Fox Business (May 10, 2013)
Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma

PR Newswire (May 10, 2013)
Early Movers: DIS, EA, OMX & More

at CNBC.com (May 7, 2013)
Retrospective analysis of linagliptin data in sub-populations with type 2 diabetes presented at AACE 22nd Annual Scientific & Clinical Congress

PR Newswire (May 6, 2013)
Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery

PR Newswire (May 6, 2013)
Lilly Declares Second-Quarter 2013 Dividend

PR Newswire (May 6, 2013)
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes

PR Newswire (May 2, 2013)
The Importance of Emergency Preparedness: Lilly Diabetes and the American College of Endocrinology (ACE) Help Prep People with Diabetes for Emergencies - Big or Small

PR Newswire (May 1, 2013)
Lilly Diabetes and Disney Publishing Worldwide Expand Collaboration

PR Newswire (Apr 30, 2013)
Lilly Celebrates National Volunteer Week with Deployment of Global Service Teams

PR Newswire (Apr 26, 2013)
Cramer: Sellers Clobbering Stocks Recklessly?

at CNBC.com (Apr 24, 2013)
Lilly Again Named One of DiversityInc's Top 50 Companies for Diversity

PR Newswire (Apr 24, 2013)
Stocks to Watch: Stocks to watch: Apple, Boeing, Sprint

at MarketWatch.com (Apr 24, 2013)
Futures Pare Gains After Durable Goods Orders

at CNBC.com (Apr 24, 2013)
Early Movers: F, BA, PG & More

at CNBC.com (Apr 24, 2013)
Lilly Reports First-Quarter 2013 Results

PR Newswire (Apr 24, 2013)
A Make-or-Break Week Ahead for the Stock Market

at CNBC.com (Apr 20, 2013)

LLY vs. ETF Alternatives

Company Description

Eli Lilly and Company (the “Company” or “Registrant”) was incorporated in 1901 in Indiana to succeed to the drug manufacturing business founded in Indianapolis, Indiana, in 1876 by Colonel Eli Lilly. We discover, develop, manufacture, and sell products in one significant business... More

Sector: Healthcare

Industry: Drug Manufacturers - Major

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Friday, May 10, 9:07 AM Eli Lilly (LLY) slips 1% premarket after saying a study of enzastaurin "did not show a statistically significant increase compared to placebo in disease-free survival" for patients with diffuse large B-cell lymphoma. LLY will discontinue development and take a $30M Q2 R&D expense. FY13 guidance unchanged. (PR) 2 Comments [Healthcare]
Tuesday, May 7, 6:20 AM Eli Lilly (LLY) declares $0.49/share quarterly dividend, in line with previous. Forward yield 3.60%. For shareholders of record May 16. Payable June 10. Ex-div date May 14. (PR) Comment! [Dividends]
Monday, May 6, 1:36 PM Merck (MRK -1.3%) gets no love today from the FDA's approval of Liptruxet late Friday, as the stock is likely dragged down with the rest of the big pharma names on the back of a CNBC report that criticizes their earnings so far. The article points to the fact that pharmaceutical companies have seen a 4.7% contraction in earnings, and a 3.2% drop in revenue this quarter. Why? Morningstar's Damien Cover says there are two primary reasons: FX impact, especially from the yen, and intensified generic competition from patent losses. Comment! [Healthcare, On the Move]
Wednesday, April 24, 3:28 PM In what seems to be a trend in companies reporting today, Eli Lilly (LLY -3.6%) dips after posting a mixed Q1, beating on a per share basis but coming up short on revenue. Net earnings rose 53% Y/Y, primarily from a gain from selling rights to a diabetes drug, but a slowdown in its Elanco animal-health kept overall revenue flat. LLY has been cultivating sales growth in its animal-health division as a strategy for getting through the wave of patent expirations, but sales in the unit rose only 2% for the quarter, compared to 21% growth during the same prior-year period. Comment! [Healthcare, Earnings, On the Move]
Wednesday, April 24, 6:31 AM Eli Lilly (LLY): Q1 EPS of $1.14 beats by $0.08. Revenue of $5.60B (flat% Y/Y) misses by $0.06B. (PR) 1 Comment [Earnings, Breaking News, Healthcare]
Wednesday, April 24, 12:05 AM Notable earnings before Wednesday’s open: ABB, ABX, ASH, ATI, AVY, BA, BYD, CFR, CKSW, COR, CP, CS, CVE, DPS, EDU, ELN, EMN, ERIC, F, FDML, GD, GLW, GRA, HCBK, HES, ICON, LAD, LL, LLY, LO, MDCO, MSI, MTH, NDAQ, NOC, NS, NVS, NYCB, OC, OCR, OSIS, PG, PLD, PX, RES, ROK, S, SO, SVU, TEL, TKR, TMO, TROW, TUP, USG, VLY, VMED, WAB, WHR, WLP, WM, WYN Comment! [Earnings]
Tuesday, April 23, 5:30 PM Notable earnings before Wednesday’s open: ABB, ABX, ASH, ATI, AVY, BA, BYD, CFR, CKSW, COR, CP, CS, CVE, DPS, EDU, ELN, EMN, ERIC, F, FDML, GD, GLW, GRA, HCBK, HES, ICON, LAD, LL, LLY, LO, MDCO, MSI, MTH, NDAQ, NOC, NS, NVS, NYCB, OC, OCR, OSIS, PG, PLD, PX, RES, ROK, S, SO, SVU, TEL, TKR, TMO, TROW, TUP, USG, VLY, VMED, WAB, WHR, WLP, WM, WYN Comment! [Earnings]
Wednesday, April 17, 8:37 AM Eli Lilly (LLY) agrees to acquire two imaging agents from Siemens (SI) that are designed to show brain deposits of tau, a protein that's linked with Alzheimer's disease and cell death. The acquisition of the agents, which are radiopharmaceutical tracers used with PET scans, add to Eli's Amyvid tracer that can detect beta amyloid, another protein linked with Alzheimer's. Financial details of the deal weren't disclosed. (PR) Comment! [Healthcare, M&A]
Tuesday, April 16, 1:38 PM Eli Lilly (LLY +1.3%) says a once-weekly treatment for type 2 diabetes (dulaglutide) met its primary efficacy endpoints in Phase III clinical trials. LLY, which could certainly use a marketed GLP-1 drug, plans to submit dulaglutide for regulatory approval this year. Comment! [Healthcare]
Thursday, April 11, 6:27 PM More on Eli Lilly (LLY): Most of the workers affected by the layoffs are part of the company’s U.S. bio-medicines division, as six of it’s blockbuster products lose their patent exclusivity over the next four years, thus allowing low-priced generic competitors to enter the market and grab away over $13B in potential business. Shares +0.4% AH. Comment! [Healthcare]
Thursday, April 11, 5:23 PM More on Eli Lilly (LLY): The drug maker acknowledged earlier that it plans to restructure its sales force and cut personnel, but still hasn't confirmed recent reports on the number of layoffs. The company says it's making the move because of changing market dynamics, and to compensate for the loss of two key patents for Cymbalta and Evista. 2 Comments [Healthcare]
Thursday, April 11, 5:03 PM Dow Jones reporting Eli Lilly (LLY) to lay off around 30% of its U.S. sales force, which accounts for about 1,000 positions. 14 Comments [Healthcare, Breaking News, Top Stories]
Wednesday, April 10, 1:37 PM Jefferies raises its price targets on big pharma names Pfizer (PFE +2.6%) ($33), Merck (MRK +2.7%) ($48), Johnson & Johnson (JNJ +0.7%) ($85), Eli Lilly (LLY +1.4%) ($44), Bristol-Myers Squibb (BMY +0.5%) ($45), AbbVie (ABBV +1.2%) ($50), and Abbot Laboratories (ABT +1.1%) ($42). "We remain positive on pharmaceuticals," Jefferies says, "valuation is attractive for most stocks." 6 Comments [Healthcare]
Thursday, April 4, 4:45 AM The cost of caring for people with dementia is $157-215B a year and could double by 2040, a study from RAND Corp. estimates. The cost of dementia treatment is $109B - above the $102B spent on heart disease and the $77B on cancer - with the other dementia expenses used for long-term day-to-day care. Companies that develop drugs for Alzheimer's disease and other conditions include Pfizer (PFE), Eli Lilly (LLY), J&J (JNJ) and Merck (MRK). 5 Comments [Healthcare]
Tuesday, April 2, 7:05 PM Citi strategists tweak the criteria for their top dividend-paying stock picks, lowering the standard for dividend yield while adding a new filter for dividend momentum “to give more emphasis on dividend safety and growth." The full list: MO, AEP, T, AVB, BMY, ED, D, DD, DUK, INTC, KMB, KRFT, LLY, MCD, MRK, MSFT, NU, NOC, OXY, PFE, PM, RTN, SRE, SO, SYY, XEL. 5 Comments [Quick Ideas]
Tuesday, April 2, 9:32 AM Eli Lilly (LLY +0.1%) is working closely with Indianapolis on a plan to invest $260M on its insulin manufacturing operations in the city and on other ancillary projects, including a $40M product-inspection center. The investment would add to a $140M scheme that Eli Lilly announced in November. (PR) Comment! [Healthcare]

Optionstrader7
$LLY Nice bounce off 100dma and recaptured 50dma. Goes ex tomorrow. LONG
May 13, 12:07 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

The Wall Street Transcript
Incyte Corporation ($INCY) and Eli Lilly ($LLY) Eye $20 Billion Market Opportunity with Rheumatoid Arthritis Drug- http://su.pr/ARL5Dl
Apr 30, 12:52 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ltfinger
Returning Downgrades (4/25/13): $AHL, $BLL, $BMY, $CAP, $CRAI, $CRR, $CRS, $HRC, $INTU, $LLY, $MLNX, $MMM, $NSH, $QCOM, $SEIC, $SWK, $SWY
Apr 26, 11:05 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

jelrod3
$LLY usually declares div around mid-April. They are 10 days late. Hmmm...
Apr 25, 5:14 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Nathaniel Matherson
Buy This Stock On Relative Weakness: $MRK $LLY $GSK http://bit.ly/YRKc3U
Apr 16, 7:46 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Dividend Sheet
$ARR $PBI and $GEO are tomorrow's best yielding ex-dividend stocks - http://stks.co/aKgZ - I like $LLY $DD $CVX and $WAG
Feb 12, 4:54 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Tradevestor
$MRK $LLY $PFE Extra tax or not, another divdend increase on its way ?http://seekingalpha.com/a/lke1
11/14/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Paul Zimbardo
Ex-Dividend Opportunities http://seekingalpha.com/a/lew9 ALE ARR DUK EXC HE LLY PBI SJR #Stocks #Dividends #News #Investing #Utilities
11/13/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Tradevestor
$MRK $BMY $PFE $LLY Why Merck might increase dividend http://seekingalpha.com/a/lerj
11/12/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Henry Swann
Goldman Sachs upgrades LLY-Eli Lilly, from a Sell to Neutral - Now how can you take them seriously? The stock is way up - what a waste.
10/9/12
Reply (6)

• !Report Abuse
View all 6 replies
Youngone91: i can only remember one goldman call being correct and that was to close crude/platinum positions in april 2011
10/15/12
• !Report Abuse
Pharma Reports: What about Cymbalta patent cliff: http://is.gd/LLYcymbalta Just on the heel of Zyprexa patent expiry
11/1/12
• !Report Abuse
Add a reply...

140 characters

LATEST REPLIES

Henry Swann
Goldman Sachs upgrades LLY-Eli Lilly, from a Sell to Neutral - Now how can you take them seriously? The stock is way up - what a waste.
10/9/12
Reply (6)

• !Report Abuse
View all 6 replies
Youngone91: i can only remember one goldman call being correct and that was to close crude/platinum positions in april 2011
10/15/12
• !Report Abuse
Pharma Reports: What about Cymbalta patent cliff: http://is.gd/LLYcymbalta Just on the heel of Zyprexa patent expiry
11/1/12
• !Report Abuse
Add a reply...

140 characters

Randy Lacen
Pharma Stocks to choose from: QCOR, SPPI, LLY, CAH, ABT, CBST, AKRX, VRTX, ANIK, USNA, CTRX
6/27/12
Reply (1)

• !Report Abuse
View all 1 replies
vireoman: Okee-doke
6/27/12
• !Report Abuse
Add a reply...

140 characters

Dividend Sheet
Five S&P 500 High Yield Stocks With Double Digit Earnings Growth + http://bit.ly/zwFuTI + $WIN $HCN $VZ $PBCT $LLY
2/25/12
Reply (3)

• !Report Abuse
View all 3 replies
Dividend Sheet: +14.42 percent for next year and -8.18 percent for the next five years
2/26/12
• !Report Abuse
Ocean Man: $3.18 for 2012 and $4.41 for 2011.
2/26/12
• !Report Abuse
Add a reply...

140 characters

Windsun33
And I see I missed out badly not selling my LLY and buying RAIL
2/17/12
Reply (3)

• !Report Abuse
View all 3 replies
nasalpancho: take out the word solar and you can ask that question every day lol
2/17/12
• !Report Abuse
Windsun33: FSTR is so thinly traded and volatile I have not really considered it. Other rail sector not doind that good today
2/17/12
• !Report Abuse
Add a reply...

140 characters

Ocean Man
Look at a 1-year chart for LLY. 34 to 42 - impressive, that's a 24% gain. That handily beats the market which was flat, and it's sector.
1/27/12
Reply (4)

• !Report Abuse
View all 4 replies
brownlee30: I second this. Been looking at adding a short position on it..
1/27/12
• !Report Abuse
mitrado: I don't short stocks... but you're right. I wouldn't buy LLY at these levels.
2/5/12
• !Report Abuse
Add a reply...

140 characters

briandiplacido
Watching LLY since Ocean's post 1/27, today read they are freezing some salaries, interesting.
2/3/12
Reply (9)

• !Report Abuse
View all 9 replies
tashe: That seems to be the plan
2/3/12
• !Report Abuse
Ocean Man: I'll likely wait 10 days to short that, don't want to be on the wrong side of any dividend run-up.
2/3/12
• !Report Abuse
Add a reply...

140 characters

Larry Smith
MAT, LLY, PFE, UPS all beat forecasts
1/31/12
Reply (2)

• !Report Abuse
View all 2 replies
mun2000: rally today big time
1/31/12
• !Report Abuse
Larry Smith: Should add ADM was a BIG miss.
1/31/12
• !Report Abuse
Add a reply...

140 characters

Ocean Man
Extremely happy w/ this week. Made $11,000 on GLD straddle w/ calls up 140%, TIF calls up 58%, LLY puts up 44%, MCD calls up 13%, AKS calls
1/27/12
Reply (8)

• !Report Abuse
View all 8 replies
Ocean Man: Thanks, guys. Working on a few ideas for next week. CLCT is current play, and I like DPS and CRZO for full-year plays.
1/28/12
• !Report Abuse
briandiplacido: CRZO my #1 horse for 2012 so far. Hope to see $30+before summer.
1/30/12
• !Report Abuse
Add a reply...

140 characters

C Meyer
Bot T 29.40 yesterday to yld 6%. LLY & AEP on today's radar.
1/27/12
Reply (1)

• !Report Abuse
View all 1 replies
Ocean Man: I'm thinking about T too. I'm about to write a Stocktalk about LLY, come join.
1/27/12
• !Report Abuse
Add a reply...

140 characters

Ocean Man
I don't know what you TA guys call it, but the LLY chart is doing that thing where it's about to go down. Bought Feb 41 puts.
1/18/12
Reply (1)

• !Report Abuse
View all 1 replies
Ocean Man: Practically free since a 50-cent dividend will be coming out of the price between now and expiration....
1/18/12
• !Report Abuse
Add a reply...

140 characters

Ryan Mallory
Short Setup on Eli Lilly LLY http://bit.ly/wCT3HH
1/13/12
Reply (2)

• !Report Abuse
View all 2 replies
Ricardo Espinosa: Looks good, thanks for the link.
1/13/12
• !Report Abuse
Ryan Mallory: No problem, Richard - glad I could help.
1/16/12
• !Report Abuse
Add a reply...

140 characters

Youngone91
sell or hold LLY?
12/15/11
Reply (2)

• !Report Abuse
View all 2 replies
Chines33: Hold.
12/15/11
• !Report Abuse
Youngone91: Ok I advised my mom to pick it up around 34, if it was my own acc I wouldn't have questioned but I try to be more conservative with her
12/15/11
• !Report Abuse
Add a reply...

140 characters

cranmer
What's up with LLY today?
12/6/11
Reply (2)

• !Report Abuse
View all 2 replies
mitrado: Speculation, baby, pure speculation! :-D I was hoping to buy some LLY stock... but now, I'll just forget that idea. It's way above my limit.
12/7/11
• !Report Abuse
mitrado: Anyway, I'm not buying anything at all before the possible market crash. Do anyone believe European leaders will come up with a good plan!?
12/7/11
• !Report Abuse
Add a reply...

140 characters

Ocean Man
Who is most likely to beat this week: C, HAL, IBM, WFC, AAPL, BAC, KO, CSX, GS, INTC, JNJ, UNH, ABT, AXP, EBAY, MS, UTX, WYNN, T, LLY, COF,
10/16/11
Reply (7)

• !Report Abuse
View all 7 replies
Hillbilly Stock Star: WYNN.......I am playing hard! Long.
10/16/11
• !Report Abuse
1ras1: i believe ms already pre announced a beat
10/16/11
• !Report Abuse
Add a reply...

140 characters

LLY Eli Lilly and Company

LLY

Eli Lilly and Company